Efficacy of avapritinib in refractory aggressive systemic mastocytosis: a single-patient case
Pol Arch Intern Med
.
2023 May 23;133(5):16471.
doi: 10.20452/pamw.16471.
Epub 2023 Mar 30.
Authors
Aneta Szudy-Szczyrek
1
,
Adrian Juda
2
,
Anna Kokoć
2
,
Witold Krupski
3
,
Justyna Szumiło
4
,
Marek Hus
2
Affiliations
1
Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland. anetaszudy@gmail.com
2
Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
3
Second Department of Medical Radiology, Medical University of Lublin, Lublin, Poland
4
Department of Clinical Pathomorphology, Medical University of Lublin, Lublin, Poland
PMID:
36994901
DOI:
10.20452/pamw.16471
No abstract available
MeSH terms
Humans
Mastocytosis, Systemic*
Pyrazoles
Pyrroles
Triazines
Substances
avapritinib
Pyrazoles
Pyrroles
Triazines